Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Lerato Mohapi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Leopold N. Aminde < Lerato Mohapi < Lesedi Tsalaile  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000481 (2017) Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie]Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
000972 (2013) Gesine Meyer-Rath [États-Unis, Afrique du Sud] ; Alana T. Brennan [États-Unis, Afrique du Sud] ; Matthew P. Fox [États-Unis, Afrique du Sud] ; Tebogo Modisenyane [Afrique du Sud] ; Nkeko Tshabangu [Afrique du Sud] ; Lerato Mohapi [Afrique du Sud] ; Sydney Rosen [États-Unis, Afrique du Sud] ; Neil Martinson [Afrique du Sud, États-Unis]Rates and cost of hospitalisation before and after initiation of antiretroviral therapy in urban and rural settings in South Africa
000E23 (2011) Ziad El-Khatib [Suède, Afrique du Sud] ; David Katzenstein [États-Unis] ; Gaetano Marrone [Suède] ; Fatima Laher [Afrique du Sud] ; Lerato Mohapi [Afrique du Sud] ; Max Petzold [Suède] ; Lynn Morris [Afrique du Sud] ; Anna Mia Ekström [Suède]Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa
000E83 (2010) Ziad El-Khatib [Suède, Afrique du Sud] ; Anna Mia Ekström [Suède] ; Johanna Ledwaba [Afrique du Sud] ; Lerato Mohapi [Afrique du Sud] ; Fatima Laher [Afrique du Sud] ; Alan Karstaedt [Afrique du Sud] ; Salome Charalambous [Afrique du Sud] ; Max Petzold [Suède] ; David Katzenstein [États-Unis] ; Lynn Morris [Afrique du Sud]nViremia and drug resistance among HIV-1 patients on antiretroviral treatment – a cross-sectional study in Soweto, South Africa
000F12 (2010) Morna Cornell [Afrique du Sud] ; Anna Grimsrud ; Lara Fairall ; Matthew P. Fox ; Gilles Van Cutsem ; Janet Giddy ; Robin Wood ; Hans Prozesky ; Lerato Mohapi ; Claire Graber ; Matthias Egger ; Andrew Boulle ; Landon MyerTemporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.
001055 (2010) Kartik K. Venkatesh [États-Unis] ; Guy De Bruyn [Afrique du Sud] ; Mark N. Lurie [États-Unis] ; Lerato Mohapi [Afrique du Sud] ; Paul Pronyk [États-Unis] ; Mosa Moshabela [Afrique du Sud] ; Edmore Marinda [Afrique du Sud] ; Glenda E. Gray [Afrique du Sud] ; Elizabeth W. Triche [États-Unis] ; Neil A. Martinson [Afrique du Sud, États-Unis]Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics
001086 (2010) Colleen F. Hanrahan [États-Unis] ; Jonathan E. Golub [États-Unis] ; Lerato Mohapi [Afrique du Sud] ; Nkeko Tshabangu [Afrique du Sud] ; Tebogo Modisenyane [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Glenda E. Gray [Afrique du Sud] ; James A. Mcintyre [Afrique du Sud] ; Neil A. Martinson [États-Unis, Afrique du Sud]Body mass index and risk of tuberculosis and death
001309 (2009) Jonathan E. Golub [États-Unis] ; Paul Pronyk [Royaume-Uni, Afrique du Sud] ; Lerato Mohapi [Afrique du Sud] ; Nkeko Thsabangu [Afrique du Sud] ; Mosa Moshabela [Afrique du Sud] ; Helen Struthers [Afrique du Sud] ; Glenda E. Gray [Afrique du Sud] ; James A. Mclntyre [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Neil A. Martinson [États-Unis, Afrique du Sud]Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa : a prospective cohort

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Adult
5Female
5Humans
5Male
4CD4 Lymphocyte Count
4HIV Infections (drug therapy)
4South Africa (epidemiology)
3Antiretroviral Therapy, Highly Active
3HIV Infections (epidemiology)
3Viral Load
2Anti-HIV Agents (therapeutic use)
2HIV Infections (virology)
2HIV-1
2HIV-1 (drug effects)
2Prospective Studies
1AIDS
1AIDS-Related Opportunistic Infections (mortality)
1Absorptiometry, Photon
1Adolescent
1Anti-HIV Agents (administration & dosage)
1Anti-HIV Agents (adverse effects)
1Anti-Retroviral Agents (therapeutic use)
1Antibacterial agent
1Antiretroviral Therapy, Highly Active (methods)
1Antituberculous agent
1Antiviral
1Body Composition
1Body Mass Index
1Cause of Death
1Chemotherapy
1Cohort Studies
1Drug Resistance, Viral
1Drug Therapy, Combination
1Emtricitabine (administration & dosage)
1Emtricitabine (adverse effects)
1Epidemiologic Methods
1HIV Infections (immunology)
1HIV Infections (metabolism)
1HIV Infections (mortality)
1HIV Infections (psychology)
1HIV Protease Inhibitors (administration & dosage)
1HIV Protease Inhibitors (adverse effects)
1HIV-1 (isolation & purification)
1HIV-Associated Lipodystrophy Syndrome (epidemiology)
1Health Knowledge, Attitudes, Practice
1Incidence
1International Cooperation
1Isoniazid
1Lamivudine (administration & dosage)
1Lamivudine (adverse effects)
1Longitudinal Studies
1Lopinavir (administration & dosage)
1Lopinavir (adverse effects)
1Lopinavir (therapeutic use)
1Middle Aged
1Obesity (mortality)
1Outcome Assessment (Health Care) (statistics & numerical data)
1Patient Acceptance of Health Care
1Patient Acceptance of Health Care (psychology)
1Patient Acceptance of Health Care (statistics & numerical data)
1Patient Compliance
1Prevention
1Primary Health Care (statistics & numerical data)
1Program Evaluation (trends)
1Raltegravir Potassium (administration & dosage)
1Raltegravir Potassium (adverse effects)
1Raltegravir Potassium (therapeutic use)
1Reverse Transcriptase Inhibitors (administration & dosage)
1Reverse Transcriptase Inhibitors (adverse effects)
1Reverse Transcriptase Inhibitors (therapeutic use)
1Risk Factors
1Risk factor
1Risk-Taking
1Ritonavir (administration & dosage)
1Ritonavir (adverse effects)
1Ritonavir (therapeutic use)
1Sexual Behavior (psychology)
1Socioeconomic Factors
1South Africa
1Sub-Saharan Africa
1Survival Analysis
1Tenofovir (administration & dosage)
1Tenofovir (adverse effects)
1Thinness (mortality)
1Treatment
1Treatment Failure
1Tuberculosis
1Tuberculosis (mortality)
1Viremia (drug therapy)
1Viremia (epidemiology)
1Viremia (virology)
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Lerato Mohapi" 
HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Lerato Mohapi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Lerato Mohapi
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024